NeuroMetrix Inc. (NURO)

Business: NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico.

IPO Date: 02-Jan-2001

Founder, Chairman, CEO, Pres & Sec.: Dr. Shai N. Gozani M.D., Ph.D.

Sr. VP, CFO & Treasurer: Mr. Thomas T. Higgins

Listing: NASDAQ: NURO

Country: United States

Headquarters: Woburn, MA

Website: https://www.neurometrix.com

Market cap: $25.95 Mln

Revenue (TTM): $8.40 Mln

Earnings (TTM): $-3.18 Mln

Cash: $23.77 Mln

Total Debt: $0.43 Mln

Insider's Holding: 1.03%

Liquidity: Low

52 Week range: $2.70 - 38.75

Shares outstanding: 7,130,090

10 Years Aggregate:

• CFO: $-69.14 Mln
• EBITDA: $-73.83 Mln
• Net Profit: $-70.88 Mln